Evidence map›Paper›PMID 33580123›Full record

ArticleScientific reports2021

Neurocognitive status and risk of mortality among people living with human immunodeficiency virus: an 18-year retrospective cohort study.

Zaeema Naveed, Howard S Fox, Christopher S Wichman, Morshed Alam, Pamela May, Christine M Arcari, Jane Meza, Steven Totusek, Lorena Baccaglini

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zaeema NaveedDepartment of Epidemiology, College of Public Health, University of Nebraska Medical Center, 984355 Medical Center, Omaha, NE, 68198-4395, USA.
Howard S FoxDepartment of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Christopher S WichmanDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
Morshed AlamDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
Pamela MayDepartment of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Christine M ArcariDepartment of Epidemiology, College of Public Health, University of Nebraska Medical Center, 984355 Medical Center, Omaha, NE, 68198-4395, USA.
Jane MezaDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
Steven TotusekDepartment of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Lorena BaccagliniDepartment of Epidemiology, College of Public Health, University of Nebraska Medical Center, 984355 Medical Center, Omaha, NE, 68198-4395, USA. lorena.baccaglini@unmc.edu.
University of Nebraska Medical Center · US

Funding

The Manhattan HIV Brain BankU24MH100931 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2013 to 2023
$14.0M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
NATIONAL NEUROLOGICAL AIDS BANKU24MH100929 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGER, ELYSE J · 2013 to 2023
$12.5M
Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
NNTC Data Coordinating CenterU24MH100925 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI FOX, HOWARD S, SHERMAN, SETH · 2013 to 2022
$9.5M
National Institutes of Health (NIH) U24MH100925NIMH NIH HHS U24 MH100928NIMH NIH HHS U24 MH100930NIMH NIH HHS U24 MH100931
6 · The paper itself

Abstract

HIV-related neurocognitive impairment (NCI) may increase the risk of death. However, a survival disadvantage for patients with NCI has not been well studied in the post-combination antiretroviral therapy (cART) era. Specifically, limited research has been conducted considering the reversible nature and variable progression of the impairment and this area demands further evaluation. We performed multivariable Cox proportional hazards modeling to assess the association between baseline NCI (global T scores) and mortality. A joint modeling approach was then used to model the trajectory of global neurocognitive functioning over time and the association between neurocognitive trajectory and mortality. Among the National NeuroAIDS Tissue Consortium's (NNTC) HIV-infected participants, we found a strong negative association between NCI and mortality in the older age groups (e.g., at age = 55, HR = 0.79; 95% CI 0.64-0.99). Three neurocognitive sub-domains (abstraction and executive functioning, speed of information processing, and motor) had the strongest negative association with mortality. Joint modelling indicated a 33% lower hazard for every 10-unit increase in global T scores (HR = 0.67; 95% CI 0.56-0.80). The study identified older HIV-infected individuals with NCI as a group needing special attention for the longevity of life. The study has considerable prognostic utility by not only predicting mortality hazard, but also future cognitive status.

Indexed as

AdultAnti-Retroviral AgentsCognitionCognitive DysfunctionCohort StudiesDatabases, FactualExecutive FunctionFemaleHIVHIV InfectionsHumansMaleMiddle AgedNeurocognitive DisordersProportional Hazards ModelsRetrospective StudiesAnti-Retroviral Agents

Identifiers

PMID33580123
PMCPMC7881128
OpenAlexW3128727305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.